When you enter multiple keywords separated by space, your search will contain results that match any of the keywords (OR search).
  • 9 Hits
  • Search Condition : Filter (MeSH = Cancer Vaccines / immunology*)
Species Resource
Human and Animal Cells TE-14(RCB2101) Implication of Highly Cytotoxic Natural Killer Cells for Esophageal Squamous Cell Carcinoma Treatment.
Human and Animal Cells LLC(RCB0558) Administration of Dendritic Cells and Anti-PD-1 Antibody Converts X-ray Irradiated Tumors Into Effective In situ Vaccines.
Human and Animal Cells iPS-MEF-Ng-20D-17(APS0001) Cancer Vaccine Therapy Using Carcinoembryonic Antigen - expressing Dendritic Cells generated from Induced Pluripotent Stem Cells.
Human and Animal Cells P53, hTERT, WT-1, and VEGFR2 are the most suitable targets for cancer vaccine therapy in HLA-A24 positive pancreatic adenocarcinoma.
Human and Animal Cells Particle-size-dependent toxicity and immunogenic activity of mesoporous silica-based adjuvants for tumor immunotherapy.
Human and Animal Cells Vaccination with antigen-transfected, NKT cell ligand-loaded, human cells elicits robust in situ immune responses by dendritic cells.
Mice C57BL/6-Ly5.1(RBRC00144) Artificially synthesized helper/killer-hybrid epitope long peptide (H/K-HELP): preparation and immunological analysis of vaccine efficacy.
DNA material AxCAmIL12p35 (RDB1414) AxCAmIL12p40 (RDB1417) The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
DNA material AxCAmIL2 (RDB1402) Dendritic cell vaccine therapy by immunization with fusion cells of interleukin-2 gene-transduced, spleen-derived dendritic cells and tumour cells.